These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20597679)

  • 41. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC.
    Briales A; Rodríguez-Martínez JM; Velasco C; Díaz de Alba P; Domínguez-Herrera J; Pachón J; Pascual A
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1266-9. PubMed ID: 21173174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
    Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
    Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
    Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
    Karczmarczyk M; Martins M; Quinn T; Leonard N; Fanning S
    Appl Environ Microbiol; 2011 Oct; 77(20):7113-20. PubMed ID: 21856834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.
    Domínguez E; Zarazaga M; Sáenz Y; Briñas L; Torres C
    Microb Drug Resist; 2002; 8(4):321-7. PubMed ID: 12523629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
    Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
    Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid detection of Escherichia coli gyrA and parC mutants in one-day-old broiler chicks in Iran.
    Abdi-Hachesoo B; Asasi K; Sharifiyazdi H
    Vet Ital; 2013; 49(3):291-7. PubMed ID: 24358491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular characterization of extraintestinal Escherichia coli isolates in Japan: relationship between sequence types and mutation patterns of quinolone resistance-determining regions analyzed by pyrosequencing.
    Aoike N; Saga T; Sakata R; Yoshizumi A; Kimura S; Iwata M; Yoshizawa S; Sugasawa Y; Ishii Y; Yamaguchi K; Tateda K
    J Clin Microbiol; 2013 Jun; 51(6):1692-8. PubMed ID: 23515543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.
    Ríos E; López MC; Rodríguez-Avial I; Pena I; Picazo JJ
    Microb Drug Resist; 2015 Oct; 21(5):512-5. PubMed ID: 25945693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
    Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V
    J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography.
    Matsumoto M; Shigemura K; Shirakawa T; Nakano Y; Miyake H; Tanaka K; Kinoshita S; Arakawa S; Kawabata M; Fujisawa M
    Int J Antimicrob Agents; 2012 Nov; 40(5):440-4. PubMed ID: 22884856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
    Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
    Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
    Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.
    Azargun R; Soroush Barhaghi MH; Samadi Kafil H; Ahangar Oskouee M; Sadeghi V; Memar MY; Ghotaslou R
    J Glob Antimicrob Resist; 2019 Jun; 17():39-43. PubMed ID: 30445211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
    J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel parC mutation potentiating fluoroquinolone resistance in Klebsiella pneumoniae and Escherichia coli clinical isolates.
    Yakout MA; Ali GH
    J Infect Dev Ctries; 2022 Feb; 16(2):314-319. PubMed ID: 35298427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of mutations in the gyrA and parC genes in Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from diseased food-producing animals.
    Liu BT; Liao XP; Yang SS; Wang XM; Li LL; Sun J; Yang YR; Fang LX; Li L; Zhao DH; Liu YH
    J Med Microbiol; 2012 Nov; 61(Pt 11):1591-1599. PubMed ID: 22878251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.